Decrease in σ but no increase in striatal dopamine D4 sites in schizophrenic brains

European Journal of Pharmacology

Volumn 314, Issue 3, 1996, Pages R3-

  Helmeste, Daiga M ^a   Tang, Siu W ^a   Bunney Jr , William E ^a   Potkin, Steven G ^a   Jones, Edward G ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Dopamine D4 receptor; Schizophrenia; Receptor

Indexed keywords

CARDIOVASCULAR AGENT; DOPAMINE 4 RECEPTOR; EMONAPRIDE; FLUOXETINE; HALOPERIDOL; RACLOPRIDE; SIGMA OPIATE RECEPTOR; THIORIDAZINE; TIOTIXENE;

ARTICLE; BRAIN REGION; BRAIN TISSUE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; SCHIZOPHRENIA;

EID: 0030608345     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(96)00702-9     Document Type: Article

References (8)

1. Akbarian, S., W.E. Bunney Jr., S.G. Potkin, S.B. Wigal, J.O, Hagman, C.A. Sandman and E.G. Jones, 1993, Altered distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase cells in frontal lobe of schizophrenics implies disturbances of cortical development. Arch. Gen. Psychiatry 50, 169.
2. 3H]nemonapride, Eur. J. Pharmacol. 301, R1.
3. 4 dopamine receptors in postmortem striatum from patients with schizophrenia, J. Neurosci. 15, 2186.
4. 4 eceptors in drug-treated schizophrenia, Eur.J. Pharmacol. 281, R5.
5. 3H]Ditolylguanidine binding to human brain a sites is diminished after haloperidol treatment, Eur. J. Pharmacol. 194, 235.
6. 4 receptors are elevated in schizophrenia, Nature 365, 441.
7. 125I]epidepride, Eur. J. Pharmacol. 286, R3.
8. 3H]raclopride binding in postmortem caudate nucleus of subjects with schizophrenia or major depression, Brain Res. 681, 109.